Never Run Out Of Buyers To Sell To.

Aegea Biotechnologies is a pioneering life science company committed to advancing precision medicine through innovative nucleic acid technologies. Our flagship Switch-Blocker™ platform enables ultra-sensitive and specific detection of rare genetic mutations, transforming diagnostics in oncology, infectious diseases, transplantation, and personalized medicine. With a robust portfolio of 11 issued U.S. patents and validated clinical applications impacting over patient samples, Aegea stands at the forefront of molecular diagnostics innovation. Our technologies seamlessly integrate with existing…
Annual Revenue$10M to $25M
Estimated OwnershipPrivateBuilt from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Matching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.